Marvin L. White

Director, Emergent BioSolutions.

Companies

Aptevo Therapeutics Inc.Chair Aug 10, 2026 to now¹
Aptevo Therapeutics Inc.Board member Aug 2, 2016 to now²
Emergent BioSolutionsBoard member Jun 3, 2010 to now³
Aptevo Therapeutics Inc.Chief executive officer Aug 2, 2016 to Aug 10, 2026²
Aptevo Therapeutics Inc.President Aug 2, 2016 to Aug 10, 2026²
Washington Prime GroupBoard member May 8, 2014 to May 19, 2016⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 6, 2026Shares withheld for tax 406 shares at $4.07 of Aptevo Therapeutics Inc.⁶
Aug 6, 2026Exercised options 1,666 shares of Aptevo Therapeutics Inc.⁶
Jul 17, 2026Exercised options 1 shares of Aptevo Therapeutics Inc.⁶
Apr 30, 2026Granted 25,344 shares of Emergent BioSolutions⁵
Jul 17, 2025Exercised options 10 shares of Aptevo Therapeutics Inc.⁷
Apr 30, 2025Granted 34,403 shares of Emergent BioSolutions⁸
Mar 3, 2025Exercised options 6 shares of Aptevo Therapeutics Inc.⁹
Mar 2, 2025Exercised options 8 shares of Aptevo Therapeutics Inc.⁹
Nov 11, 2024Sold 14,287 shares at $11.97 of Emergent BioSolutions¹⁰
May 23, 2024Granted 17,430 shares of Emergent BioSolutions¹¹
Mar 3, 2024Exercised options 9,584 shares of Aptevo Therapeutics Inc.¹²
Mar 2, 2024Exercised options 12,917 shares of Aptevo Therapeutics Inc.¹²
Jan 28, 2024Exercised options 4,792 shares of Aptevo Therapeutics Inc.¹³
May 25, 2023Granted 33,847 shares of Emergent BioSolutions¹⁴
Mar 3, 2023Exercised options 9,582 shares of Aptevo Therapeutics Inc.¹⁵
Jan 29, 2023Exercised options 4,791 shares of Aptevo Therapeutics Inc.¹⁶
May 26, 2022Granted 8,446 shares of Emergent BioSolutions¹⁷
Jan 29, 2022Exercised options 4,792 shares of Aptevo Therapeutics Inc.¹⁸

The numbers on this page point here. Each one links to the record it came from.